Medicine and Dentistry
Disease
91%
Resuscitation
68%
Malignant Neoplasm
64%
Breast Cancer
51%
Asthma
46%
Heart Failure
43%
Coccidioidomycosis
42%
Heart Arrest
42%
Chronic Obstructive Pulmonary Disease
40%
Women's Health
40%
Symptom
40%
Infection
38%
Osteoarthritis
36%
Postmenopause
36%
Physical Activity
35%
Biological Marker
34%
Cardiovascular System
30%
Hazard Ratio
29%
Neoplasm
29%
Pulmonary Hypertension
28%
Odds Ratio
28%
Magnetic Resonance Imaging
28%
Clinical Trial
27%
COVID-19
26%
Prevalence
25%
Myocardial Infarction
25%
Systematic Review
25%
Ventricular Fibrillation
25%
Cardiovascular Disease
25%
Knee Osteoarthritis
24%
Out of Hospital Cardiac Arrest
20%
Body Mass Index
20%
Knee
20%
In Vitro
20%
Diagnosis
20%
Injury
19%
Placebo
19%
Health Care Cost
18%
Percutaneous Coronary Intervention
18%
Ovarian Cancer
18%
Pediatrics
18%
Drug Therapy
18%
Diabetes
17%
Obstructive Sleep Apnea
17%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Transplantation
16%
Meta-Analysis
16%
Hemodynamic
16%
Acute Heart Infarction
16%
Cohort Analysis
16%
Medicine
16%
Randomized Controlled Trial
15%
Quality of Life
15%
Coronary Artery Disease
14%
Obesity
14%
Cancer Risk
14%
Severe Asthma
14%
Adverse Event
14%
Frailty
14%
Diabetes Mellitus
14%
Liver Cirrhosis
13%
Maturity Onset Diabetes of the Young
13%
Coronary Angiography
13%
Wheeze
13%
Coronary Artery
12%
Personalized Medicine
12%
Clinician
12%
Logistic Regression Analysis
12%
Cardiopulmonary Resuscitation
12%
Nodular Melanoma
12%
Apoplexy
12%
Colorectal Cancer
11%
Forced Expiratory Volume
11%
Public Health
11%
Observational Study
11%
Childbirth
11%
Nicotinamide Phosphoribosyltransferase
11%
Gene Expression
11%
Cardiac Catheterization
11%
Smoking
11%
Cardiomyopathy
11%
Endothelial Cell
10%
Skeletal Muscle
10%
Infarction
10%
Primary Health Care
10%
Single-Photon Emission Computed Tomography
10%
Saphenous Vein Graft
10%
Combination Therapy
10%
Insulin Resistance
10%
Dietary Pattern
9%
Wellbeing
9%
Proportional Hazards Model
9%
Positive Airway Pressure
9%
Platelet
9%
Prostate Cancer
9%
Arm
9%
Acute Respiratory Distress Syndrome
9%
Atrial Fibrillation
9%
Overall Survival
9%
Geriatrics
9%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Heart Failure
46%
Mouse
45%
Asthma
42%
Coccidioidomycosis
41%
Infection
37%
Malignant Neoplasm
33%
Placebo
33%
Heart Infarction
30%
Clinical Trial
29%
Pulmonary Hypertension
28%
Symptom
27%
Breast Cancer
26%
Chronic Obstructive Lung Disease
24%
Biological Marker
22%
Neoplasm
21%
Cardiovascular Disease
20%
Adverse Event
19%
Receptor
18%
Inflammation
18%
Sleep Disordered Breathing
17%
Prevalence
17%
Cohort Study
16%
Benzo(a)pyrene
16%
Injury
16%
Muscarinic Receptor
15%
Acute Heart Infarction
15%
Acetylsalicylic Acid
15%
Randomized Controlled Trial
15%
Atrial Fibrillation
14%
Opiate Receptor
14%
Combination Therapy
14%
Coronary Artery Disease
13%
Pharmacokinetics
13%
Heart Arrest
13%
Chemotherapy
12%
Heart Failure with Preserved Ejection Fraction
12%
SARS Coronavirus
12%
Ovary Cancer
12%
Adult Respiratory Distress Syndrome
11%
Comorbidity
11%
Progression Free Survival
11%
Cardiomyopathy
11%
All Cause Mortality
10%
Paclitaxel
10%
Frailty
10%
Heart Ventricle Fibrillation
10%
Acute Lung Injury
9%
Lung Disease
9%
Coccidioides Immitis
9%
Opiate
9%
Diabetes Mellitus
9%
Overall Survival
9%
Mouse Model
8%
Insulin Resistance
8%
Lung Cancer
8%
Coronavirinae
8%
Captopril
8%
Fibrosing Alveolitis
8%
Melanoma
8%
Phosphotransferase
8%
Reactive Oxygen Metabolite
8%
Dry Powder Inhaler
8%
Cytokine
8%
Coccidioides
7%
Nitric Oxide
7%
Pirenzepine
7%
Randomized Clinical Trial
7%
Osteoarthritis
7%
Spironolactone
7%
Fluconazole
7%
Adrenergic Receptor
7%
Syndrome
7%
Wheezing
7%
Colorectal Cancer
7%
HIV
7%
Heart Left Ventricle Failure
7%
Sprague Dawley Rat
7%
Ischemic Heart Disease
6%
Infarction
6%
Turmeric
6%
Observational Study
6%
Obesity
6%
Heart Arrhythmia
6%
Gemcitabine
6%
Glucocorticoid
6%
Digoxin
6%
Carcinogenesis
6%
Nanoparticle
6%
Epileptic Absence
6%
Antihypertensive Agent
6%
Atherogenesis
6%
Sleep Disorder
6%
Out of Hospital Cardiac Arrest
6%
Liver Cirrhosis
6%
Lipopolysaccharide
6%
Cisplatin
6%
Biliary Tract Cancer
6%
Nicotinamide Phosphoribosyltransferase
6%
Nonalcoholic Fatty Liver
6%
Keyphrases
Coccidioidomycosis
36%
Women's Health Initiative
27%
Asthma
26%
Confidence Interval
25%
Postmenopausal Women
18%
Chronic Obstructive Pulmonary Disease
16%
Physical Activity
14%
Heart Failure
14%
Hazard Ratio
14%
Body Mass Index
13%
United States
13%
Cardiopulmonary Resuscitation
13%
Placebo
13%
Cardiac Arrest
13%
Obesity
13%
Older Adults
12%
Risk Factors
12%
Odds Ratio
12%
Myocardial Infarction
11%
Clinical Trials
11%
Cardiovascular Disease
11%
Coccidioides Immitis
10%
Out-of-hospital Cardiac Arrest
10%
Lung Function
10%
COVID-19
10%
Arizona
10%
Lung
9%
Muscarinic Receptors
9%
Insulin
9%
Breast Cancer
9%
Chest Compression
9%
Ventricular Fibrillation
8%
Sleep Duration
8%
Severe Asthma
8%
Pulmonary Hypertension
8%
Coronary Artery Disease
8%
High Risk
7%
Pulmonary Arterial Hypertension
7%
Randomized Clinical Trial
7%
Coronary Angiography
7%
Heart Failure with Preserved Ejection Fraction (HFpEF)
7%
Phosphorylation
7%
Tumor
7%
Quality of Life
7%
Diabetes
7%
Insulin Resistance
7%
Resuscitation
7%
Left Ventricular Function
7%
Knee Osteoarthritis
7%
Trauma Resuscitation
7%
Opioid Receptors
7%
Frailty
6%
Percutaneous Coronary Intervention
6%
Overall Survival
6%
Osteoarthritis
6%
In Cancer
6%
Acute Myocardial Infarction
6%
Hispanic
6%
Forced Expiratory Volume in 1 Second (FEV1)
6%
Aging
6%
T Cells
6%
Central Nervous System
6%
Pirenzepine
6%
Chemotherapy
6%
Insomnia
6%
Obstructive Sleep Apnea
6%
Meta-analysis
6%
Randomized Trial
6%
Tucson
5%
Precision Medicine
5%
Muscarinic Cholinergic Receptor
5%
Systematic Meta-analysis
5%
Race-ethnicity
5%
Randomized Controlled Trial
5%
Type 1 Diabetes Mellitus (T1DM)
5%
Atrial Fibrillation
5%
Survivors
5%
Osteoarthritis Initiative
5%
Clinical Outcomes
5%
Hypertension
5%
Congestive Heart Failure
5%
Chaperone-rich Cell Lysate
5%
Improved Outcomes
5%
Protein Kinase
5%
Sleep Health
5%
African Ancestry
5%
Cancer Survivors
5%
Type 2 Diabetes Mellitus (T2DM)
5%
Soleus muscle
5%
Body Composition
5%
Vascular Smooth muscle Cells
5%
Comorbidity
5%